MDMA Moves from Party Drug Back to Thera...

In this episode of Science Quickly, host Rachel Feltman interviews physician Anuja Dokras about the long road to changing the name of the condition PCOS, or polycystic ovary syndrome, to polyendocrine metabolic ovarian syndrome, or PMOS. The conversation covers why “PCOS” was mis ... Show More

From the mystery of why elevator waits feel endless to the surprisingly tricky problem of splitting a pizza (or even a sandwich) fairly, this episode explores how math shapes everyday experiences in ways you might not expect. Host Rachel Feltman talks with physicist and editor Ma ... Show More

In this episode of Science Quickly, host Rachel Feltman and Scientific American senior desk editor for health and medicine Tanya Lewis break down the fast-growing Ebola outbreak—caused by a viral species with no approved vaccine—in the Democratic Republic of the Congo and Uganda. ... Show More

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ... Show More

In this episode, I discuss Methyl​enedioxy​methamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applications for the treatment of post-traum ... Show More

Once a party drug, ketamine has found its way into modern medicine. 

<p>In the form of recreational ecstasy, the psychoactive drug MDMA carries with it a stigma of wide-eyed ravers, free love and counterculture pharmacological spirituality. But beyond its cultural legacy, MDMA offers a potent therapeutic tool for doctors and therapists -- if we ca ... Show More

<p>In this episode, Rick Doblin, founder and executive director of MAPS, discusses MDMA, a molecule that has (at a minimum) revolutionary therapeutic benefits for PTSD, but arguably could have, at the highest order, a lasting impact on humanity's ability to peacefully coexist. Ri ... Show More

<p>In this episode, Kyle and Joe interview Ben Sessa, a Consultant Psychiatrist. Ben comes on the show to talk about preliminary results from the first ever, MDMA assisted therapy for alcohol use disorder (AUD).<strong><br /></strong></p> <h1>3 Key Points:</h1> <ol> <li>Ben Sessa ... Show More

Molly, ecstasy, MDMA: whatever you call it, this drug is blowing up. Some say MDMA can be a legitimate medicine to treat conditions like PTSD. But others reckon it's a dangerous drug that can fry your brain, and even kill you — from just one bad pill. Who's right? That's what we' ... Show More

<p>Psychedelics have gotten very popular in the past few years for their therapeutic properties, but how much do you know about them? In this episode, I am going to talk about MDMA, which has a better success rate for PTSD than anything... ever! If all goes well with the FDA tria ... Show More

It ain’t easy getting old but the right drugs, used in the right ways, can help. Charley Wininger is a psychotherapist, called “The Love Doctor,” who recently authored of Listening to Ecstasy: The Transformative Power of MDMA. I talked with him and his wife, Shelley, about the wa ... Show More